Bromocriptine mesylate in type 2 diabetes mellitus: A novel approach

Journal Title: International Journal of Medical Science and Public Health - Year 2017, Vol 6, Issue 6

Abstract

Type 2 diabetes mellitus (T2DM) remains uncontrolled in a large number of patients despite advances in medical treatment. Bromocriptine mesylate is a quick release preparation of bromocriptine, which acts on hypothalamic pathways of glucose metabolism. It represents a novel therapeutic option in the management of T2DM. United States Food and Drug Administration in 2009 approved the use of bromocriptine mesylate in T2DM as an adjunct to diet and exercise. Various clinical trials have demonstrated the efficacy of bromocriptine mesylate in lowering glycosylated hemoglobin by 0.4 to 0.8% as monotherapy or add-on therapy with other antidiabetic agents. Action on central pathways affecting glucose metabolism makes it a great alternative to current modalities of treatment for T2DM.

Authors and Affiliations

Kapil Kumar Garg, SN Chugh

Keywords

Related Articles

 Healthy aging conceptualizations in Saudi Arabia: a systematic review

 The concepts of healthy aging have been growing in recent years. Based on searches of literature on aging, there are limited studies that address healthy aging issues for older population in Saudi Arabia. A system...

A prospective study of adverse effects and compliance of intravenous iron sucrose for the treatment of severe anemia in ante- and post-natal women

Background: Anemia is a leading cause of maternal death in the world. About half of it occur in southeast Asia and among them, 80% occur in India. Nowadays, intravenous (IV) iron sucrose is started for the therapy of sev...

Impact of cardiopulmonary resuscitation training in 1st year of MBBS

Background: The present medical education system fails to inculcate appropriate skills and competence to the students to serve the community. As the world is moving toward the system of “need-based education,” the traini...

 Prevalence and antimicrobial susceptibility pattern of methiciliin resistant Staphyllocococcus Aureus in tertiary care teaching hospital - Western India

 Background: Methicillin resistant Staphylococcus aureus (MRSA) infection traditionally has been associated with healthcare settings, colonizing patients with underlying debilitating health conditions. Now a day, H...

Acute myeloid leukemia presenting as pancytopenia—a rare case

Pancytopenia is a diagnostic dilemma that can be caused in several conditions. Patients with pancytopenia should be evaluated thoroughly to find the causative factors using detailed clinical history and investigations....

Download PDF file
  • EP ID EP315216
  • DOI 10.5455/ijmsph.2017.0308007042017
  • Views 78
  • Downloads 0

How To Cite

Kapil Kumar Garg, SN Chugh (2017). Bromocriptine mesylate in type 2 diabetes mellitus: A novel approach. International Journal of Medical Science and Public Health, 6(6), 987-991. https://europub.co.uk/articles/-A-315216